Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92


Epithelial-Mesenchymal Transition during Metastasis of HPV-Negative Pharyngeal Squamous Cell Carcinoma.

Ihler F, Gratz R, Wolff HA, Weiss BG, Bertlich M, Kitz J, Salinas G, Rave-Fränk M, Canis M.

Biomed Res Int. 2018 Mar 6;2018:7929104. doi: 10.1155/2018/7929104. eCollection 2018.


Presentation of a variation of the chorioallantoic membrane set up as a potential model for individual therapy for squamous cell carcinoma of the oropharynx.

Kauffmann P, Troeltzsch M, Cordesmeyer R, Heidekrueger PI, Schliephake H, Canis M, Wolff HA, Rave-Fraenk M, Stroebel P, Kehrer A, Prantl L, Aung T.

Clin Hemorheol Microcirc. 2017;67(3-4):453-457. doi: 10.3233/CH-179226.


Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.

Emons G, Spitzner M, Reineke S, Möller J, Auslander N, Kramer F, Hu Y, Beissbarth T, Wolff HA, Rave-Fränk M, Heßmann E, Gaedcke J, Ghadimi BM, Johnsen SA, Ried T, Grade M.

Mol Cancer Res. 2017 Nov;15(11):1481-1490. doi: 10.1158/1541-7786.MCR-17-0205. Epub 2017 Aug 15.


The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.

Rühlmann F, Nietert M, Sprenger T, Wolff HA, Homayounfar K, Middel P, Bohnenberger H, Beissbarth T, Ghadimi BM, Liersch T, Conradi LC.

J Cancer. 2017 Apr 10;8(7):1229-1237. doi: 10.7150/jca.16980. eCollection 2017.


Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.

Jo P, Azizian A, Salendo J, Kramer F, Bernhardt M, Wolff HA, Gruber J, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J.

Int J Mol Sci. 2017 May 27;18(6). pii: E1140. doi: 10.3390/ijms18061140.


Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients.

Weiss BG, Ihler F, Wolff HA, Schneider S, Canis M, Steiner W, Welz C.

Head Neck. 2017 Aug;39(8):1631-1638. doi: 10.1002/hed.24814. Epub 2017 May 5.


Feasibility study of entrance and exit dose measurements at the contra lateral breast with alanine/electron spin resonance dosimetry in volumetric modulated radiotherapy of breast cancer.

Wagner DM, Hüttenrauch P, Anton M, von Voigts-Rhetz P, Zink K, Wolff HA.

Phys Med Biol. 2017 Jul 7;62(13):5462-5472. doi: 10.1088/1361-6560/aa6ee2. Epub 2017 Apr 24.


Transoral laser microsurgery for T1b glottic cancer: review of 51 cases.

Weiss BG, Ihler F, Pilavakis Y, Wolff HA, Canis M, Welz C, Steiner W.

Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1997-2004. doi: 10.1007/s00405-016-4432-4. Epub 2016 Dec 27.


Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies.

Jo P, Nietert M, Gusky L, Kitz J, Conradi LC, Müller-Dornieden A, Schüler P, Wolff HA, Rüschoff J, Ströbel P, Grade M, Liersch T, Beißbarth T, Ghadimi MB, Sax U, Gaedcke J.

Sci Rep. 2016 Oct 18;6:35589. doi: 10.1038/srep35589.


T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.

Beschel LM, Leu M, Reichardt SD, Rave-Fränk M, Schirmer MA, Stadelmann C, Canis M, Wolff HA, Reichardt HM.

Oncotarget. 2016 Oct 4;7(40):65902-65915. doi: 10.18632/oncotarget.11677.


Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group.

Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R.

Klin Padiatr. 2016 Apr;228(3):105-12. doi: 10.1055/s-0041-111180. Epub 2016 May 2. Review.


Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.

Azizian A, Epping I, Kramer F, Jo P, Bernhardt M, Kitz J, Salinas G, Wolff HA, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J.

Int J Mol Sci. 2016 Apr 15;17(4):568. doi: 10.3390/ijms17040568.


Heterogeneity of KRAS Mutation Status in Rectal Cancer.

Jo P, König A, Schirmer M, Kitz J, Conradi LC, Azizian A, Bernhardt M, Wolff HA, Grade M, Ghadimi M, Ströbel P, Schildhaus HU, Gaedcke J.

PLoS One. 2016 Apr 11;11(4):e0153278. doi: 10.1371/journal.pone.0153278. eCollection 2016.


Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.

Dröge LH, Weber HE, Guhlich M, Leu M, Conradi LC, Gaedcke J, Hennies S, Herrmann MK, Rave-Fränk M, Wolff HA.

BMC Cancer. 2015 Oct 20;15:750. doi: 10.1186/s12885-015-1812-x.


Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.

Rave-Fränk M, Tehrany N, Kitz J, Leu M, Weber HE, Burfeind P, Schliephake H, Canis M, Beissbarth T, Reichardt HM, Wolff HA.

Strahlenther Onkol. 2016 Jan;192(1):47-54. doi: 10.1007/s00066-015-0892-5. Epub 2015 Sep 15.


The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study.

Siam L, Bleckmann A, Chaung HN, Mohr A, Klemm F, Barrantes-Freer A, Blazquez R, Wolff HA, Lüke F, Rohde V, Stadelmann C, Pukrop T.

Oncotarget. 2015 Oct 6;6(30):29254-67. doi: 10.18632/oncotarget.4201.


Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group.

Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.


Role of PECAM-1 in radiation-induced liver inflammation.

Malik IA, Stange I, Martius G, Cameron S, Rave-Fränk M, Hess CF, Ellenrieder V, Wolff HA.

J Cell Mol Med. 2015 Oct;19(10):2441-52. doi: 10.1111/jcmm.12630. Epub 2015 Jul 14.


Volumetric intensity-modulated arc therapy vs. 3-dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: Effects on treatment-related side effects and survival.

Weber HE, Dröge LH, Hennies S, Herrmann MK, Gaedcke J, Wolff HA.

Strahlenther Onkol. 2015 Nov;191(11):827-34. doi: 10.1007/s00066-015-0859-6. Epub 2015 Jun 8.


Surgical margins and oncologic results after carcinoma of the external auditory canal.

Ihler F, Koopmann M, Weiss BG, Dröge LH, Durisin M, Christiansen H, Weiß D, Canis M, Wolff HA.

Laryngoscope. 2015 Sep;125(9):2107-12. doi: 10.1002/lary.25381. Epub 2015 May 25.


Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer.

Azizian A, Kramer F, Jo P, Wolff HA, Beißbarth T, Skarupke R, Bernhardt M, Grade M, Ghadimi BM, Gaedcke J.

World J Surg. 2015 Sep;39(9):2329-35. doi: 10.1007/s00268-015-3083-8.


HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.

Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC.

Oncotarget. 2015 Jun 20;6(17):15065-76.


(Chemo)radiotherapy after laser microsurgery and selective neck dissection for pN2 head and neck cancer.

Wolff HA, Ihler F, Zeller N, Welz C, Jung K, Canis M, Steiner W.

Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1533-41. doi: 10.1007/s00405-015-3619-4. Epub 2015 Apr 12.


The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse model.

Martius G, Cameron S, Rave-Fränk M, Hess CF, Wolff HA, Malik IA.

Int J Mol Sci. 2015 Mar 2;16(3):4682-97. doi: 10.3390/ijms16034682.


High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.

Tehrany N, Kitz J, Rave-Fränk M, Lorenzen S, Li L, Küffer S, Hess CF, Burfeind P, Reichardt HM, Canis M, Beissbarth T, Wolff HA.

Strahlenther Onkol. 2015 Jul;191(7):566-72. doi: 10.1007/s00066-014-0801-3. Epub 2015 Jan 10.


STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy.

Spitzner M, Ebner R, Wolff HA, Ghadimi BM, Wienands J, Grade M.

Cancers (Basel). 2014 Sep 29;6(4):1986-2011. doi: 10.3390/cancers6041986. Review.


Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.

Gaedcke J, Leha A, Claus R, Weichenhan D, Jung K, Kitz J, Grade M, Wolff HA, Jo P, Doyen J, Gérard JP, Johnsen SA, Plass C, Beißbarth T, Ghadimi M.

Oncotarget. 2014 Sep 30;5(18):8123-35.


Quality of life in patients after resection of pT3 lateral tongue carcinoma: Microvascular reconstruction versus primary closure.

Canis M, Weiss BG, Ihler F, Hummers-Pradier E, Matthias C, Wolff HA.

Head Neck. 2016 Jan;38(1):89-94. doi: 10.1002/hed.23862. Epub 2015 Jun 16.


Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

Rödel F, Wieland U, Fraunholz I, Kitz J, Rave-Fränk M, Wolff HA, Weiss C, Wirtz R, Balermpas P, Fokas E, Rödel C.

Int J Cancer. 2015 Jan 15;136(2):278-88. doi: 10.1002/ijc.28979. Epub 2014 May 27.


Oncologic results of transoral laser microsurgery for squamous cell carcinoma of the posterior pharyngeal wall.

Canis M, Wolff HA, Ihler F, Matthias C, Steiner W.

Head Neck. 2015 Feb;37(2):156-61. doi: 10.1002/hed.23571. Epub 2014 Feb 12.


Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.

Quack H, Erpenbeck L, Wolff HA, Sprenger T, Seitz CS, Schön MP, Neumann S, Stanek K, Ghadimi BM, Michels B, Middel P, Schaefer IM, Liersch T, Conradi LC.

Case Rep Oncol. 2013 Dec 11;6(3):609-15. doi: 10.1159/000357166. eCollection 2013 Sep.


Fractionated external beam radiotherapy of skull base metastases with cranial nerve involvement.

Dröge LH, Hinsche T, Canis M, Alt-Epping B, Hess CF, Wolff HA.

Strahlenther Onkol. 2014 Feb;190(2):199-203. doi: 10.1007/s00066-013-0460-9. Epub 2013 Dec 22.


Ionizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII.

Sag CM, Wolff HA, Neumann K, Opiela MK, Zhang J, Steuer F, Sowa T, Gupta S, Schirmer M, Hünlich M, Rave-Fränk M, Hess CF, Anderson ME, Shah AM, Christiansen H, Maier LS.

Basic Res Cardiol. 2013 Nov;108(6):385. doi: 10.1007/s00395-013-0385-6. Epub 2013 Sep 26.


STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.

Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beissbarth T, Kitz J, Wienands J, Ghadimi BM, Ebner R, Ried T, Grade M.

Int J Cancer. 2014 Feb 15;134(4):997-1007. doi: 10.1002/ijc.28429. Epub 2013 Sep 3.


Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.

Salendo J, Spitzner M, Kramer F, Zhang X, Jo P, Wolff HA, Kitz J, Kaulfuß S, Beißbarth T, Dobbelstein M, Ghadimi M, Grade M, Gaedcke J.

Radiother Oncol. 2013 Sep;108(3):451-7. doi: 10.1016/j.radonc.2013.06.032. Epub 2013 Aug 7.


Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.

Wolff HA, Wolff CR, Hess CF, Jung K, Sennhenn-Kirchner S, Hinterthaner M, Müller-Dornieden A, Körber W, Marten-Engelke K, Roedel R, Christiansen H, Engelke C.

Strahlenther Onkol. 2013 Oct;189(10):874-80. doi: 10.1007/s00066-013-0404-4. Epub 2013 Jul 12.


Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial.

Wolff HA, Conradi LC, Beissbarth T, Leha A, Hohenberger W, Merkel S, Fietkau R, Raab HR, Tschmelitsch J, Hess CF, Becker H, Wittekind C, Sauer R, Rödel C, Liersch T; German Rectal Cancer Study Group.

Radiother Oncol. 2013 Jul;108(1):48-54. doi: 10.1016/j.radonc.2013.05.009. Epub 2013 Jun 11.


Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.

Canis M, Martin A, Ihler F, Wolff HA, Kron M, Matthias C, Steiner W.

Head Neck. 2014 Jun;36(6):859-66. doi: 10.1002/hed.23389. Epub 2013 Sep 2.


Enoral laser microsurgery for squamous cell carcinoma of the oral cavity.

Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W.

Head Neck. 2014 Jun;36(6):787-94. doi: 10.1002/hed.23365. Epub 2013 Aug 1.


Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.

Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W.

Head Neck. 2014 May;36(5):652-9. doi: 10.1002/hed.23338. Epub 2013 Jul 2.


Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma.

Hennies S, Hermann RM, Gaedcke J, Grade M, Hess CF, Christiansen H, Wolff HA.

Dis Esophagus. 2014 Feb-Mar;27(2):146-51. doi: 10.1111/dote.12067. Epub 2013 Apr 9.


Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option?

Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W.

Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2719-27. doi: 10.1007/s00405-013-2382-7. Epub 2013 Feb 14.


[Primary curative radiochemotherapy in nasopharyngeal carcinomas. Cumulative total cisplatin dose of prognostic significance].

Christiansen H, Wolff HA.

Strahlenther Onkol. 2013 Mar;189(3):269-70. doi: 10.1007/s00066-012-0285-y. German. No abstract available.


Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients.

Canis M, Martin A, Ihler F, Wolff HA, Kron M, Matthias C, Steiner W.

Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2315-26. doi: 10.1007/s00405-012-2327-6. Epub 2013 Jan 10.


Frequency of HER-2 positivity in rectal cancer and prognosis.

Conradi LC, Styczen H, Sprenger T, Wolff HA, Rödel C, Nietert M, Homayounfar K, Gaedcke J, Kitz J, Talaulicar R, Becker H, Ghadimi M, Middel P, Beissbarth T, Rüschoff J, Liersch T.

Am J Surg Pathol. 2013 Apr;37(4):522-31. doi: 10.1097/PAS.0b013e318272ff4d.


Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil.

Canis M, Martin A, Kron M, Konstantinou A, Ihler F, Wolff HA, Matthias C, Steiner W.

Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2299-306. doi: 10.1007/s00405-012-2335-6. Epub 2012 Dec 29.


[Reversible unilateral blindness].

Naxer S, Hille A, Wolff HA, Schittkowski MP.

Klin Monbl Augenheilkd. 2012 Oct;229(10):1018-20. doi: 10.1055/s-0032-1315373. Epub 2012 Sep 25. German. No abstract available.


Testicular radiation dose after multimodal curative therapy for locally advanced rectal cancer. Influence on hormone levels, quality of life, and sexual functioning.

Hennies S, Wolff HA, Jung K, Rave-Fränk M, Gaedcke J, Ghadimi M, Hess CF, Becker H, Hermann RM, Christiansen H.

Strahlenther Onkol. 2012 Oct;188(10):926-32. Epub 2012 Aug 11.


Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma.

Canis M, Ihler F, Wolff HA, Christiansen H, Matthias C, Steiner W.

Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1075-83. doi: 10.1007/s00405-012-2097-1. Epub 2012 Jul 5.


Supplemental Content

Loading ...
Support Center